Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment

Details Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment

1980-11-17

1982-01-19

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Fermentate of unknown chemical structure

Having a known elemental analysis

435169, 435170, A61K 3500

Patent

active

043116930

ABSTRACT:
The antibiotic MSD A63A, having antibacterial and growth-permittant activity, is produced by fermentation of Streptoverticillum hiroshimense MA4845 (ATCC 31586), in a suitable nutrient media.

Affiliated with

Also associated with

Rating

Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Discovery of MSD A63A, a new efrotomycin-line antibiotic ferment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1915059